Drug Delivery

Bavarian Nordic to supply smallpox and monkeypox vaccine to Switzerland

Bavarian Nordic has received an order from the Swiss Armed Forces and the Swiss Federal Office of Public Health for its Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox and monkeypox vaccine doses.

Bavarian Nordic and PAHO sign agreement for monkeypox vaccines

Bavarian Nordic has signed a supply agreement with the Pan American Health Organization (PAHO) for its monkeypox vaccine.

Eli Lilly launches citrate-free Taltz formulation

Eli Lilly and Company has announced that its Taltz (ixekizumab) 80mg/mL injection is now available in a new, citrate-free formulation.

Bavarian Nordic to supply additional monkeypox vaccine doses to US

Bavarian Nordic has received an order from the US Biomedical Advanced Research and Development Authority (BARDA) for additional doses of Jynneos, a non-replicating vaccine against smallpox and monkeypox.

US buys additional Bavarian Nordic’s smallpox and monkeypox vaccine doses

The US Biomedical Advanced Research and Development Authority (BARDA) has ordered additional doses of Bavarian Nordic’s Jynneos, a non-replicating vaccine to prevent smallpox and monkeypox.

Axsome Therapeutics signs agreement for Sunosi acquisition

Biopharmaceutical firm Axsome Therapeutics has signed a definitive agreement with Jazz Pharmaceuticals to acquire Sunosi (solriamfetol), in a deal valued at $53m.

Altamira, Nuance Pharma sign distribution deal for Bentrio in Asian markets

Altamira Therapeutics has signed an exclusive licensing and distribution agreement with Nuance Pharma for its nasal spray, Bentrio (AM-301), in Chinese Mainland, Hong Kong, Macau and South Korea.

Merck, Ridgeback to supply 1.75 million molnupiravir courses to UK

Merck and its partner Ridgeback Biotherapeutics have received an order from the UK Government to supply an additional 1.75 million patient courses of investigational Covid-19 oral antiviral drug molnupiravir (MK-4482).

Allergan announces availability of VUITY in US pharmacies

AbbVie’s subsidiary Allergan has announced the availability of FDA-approved eye drop, VUITY (pilocarpine HCl ophthalmic solution) 1.25%, by prescription in pharmacies across the US.